A novel mutation in an atypical presentation of the rare infantile Farber disease

被引:9
作者
Al Jasmi, Fatma [1 ]
机构
[1] UAE Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates
关键词
Farber disease; Acid ceramidase; Farber lipogranulomatosis; A S A H I; ACID CERAMIDASE; DEFICIENCY;
D O I
10.1016/j.braindev.2011.09.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Farber disease (MIM 228000) is a rare autosomal recessive condition caused by deficiency of lysosomal acid ceramidase (EC 3.5.1.23). The disease presents classically during the infantile period with a characteristic triad of clinical manifestations: (a) painful joints, (b) subcutaneous nodules, and (c) progressive hoarseness due to laryngeal involvement. All cases reported in the literature to date have presented with the above features, except for the neonatal-visceral subtype. Methods: Here we describe a 2-year-old female, a product of a non-consanguineous Emirati union, who was quite well until 8 months of age when presented with failure to thrive, developmental delay with relative sparing of cognitive function, cherry-red spot, painful joint, progressive limitation of joint movement, and hoarseness of voice. The sibling of patient died with similar presentation and the nerve biopsy of deceased sibling showed features consistent with Farber disease. Results: Gene sequencing of the A S A H I gene confirmed the diagnosis of Farber disease. Our patient has two heterozygous novel mutations, one in exon 8 (c.533 T > C) and the other in exon 13 (c.1144 A > C). The carrier status of the parents was confirmed. Conclusions: Farber disease is well known for its striking unique triad of symptoms. This study demonstrates that not all the cases essentially present with subcutaneous nodules which is considered a hallmark of the disease. (c) 2011 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:533 / 535
页数:3
相关论文
共 10 条
[1]   Molecular analysis of acid ceramidase deficiency in patients with Farber disease [J].
Bär, J ;
Linke, T ;
Ferlinz, K ;
Neumann, U ;
Schuchman, EH ;
Sandhoff, K .
HUMAN MUTATION, 2001, 17 (03) :199-209
[2]   Farber lipogranulomatosis: clinical and molecular genetic analysis reveals a novel mutation in an Indian family [J].
Devi, Akela Radha Rama ;
Gopikrishna, Munimanda ;
Ratheesh, Raman ;
Savithri, Gorinabele ;
Swarnalata, Gowrishankar ;
Bashyam, Murali .
JOURNAL OF HUMAN GENETICS, 2006, 51 (09) :811-814
[3]  
Ehlert Karoline, 2007, Pediatr Rheumatol Online J, V5, P15
[4]  
FARBER S, 1957, J Mt Sinai Hosp N Y, V24, P816
[5]   A CASE OF COMBINED FARBER AND SANDHOFF DISEASE [J].
FUSCH, C ;
HUENGES, R ;
MOSER, HW ;
SEWELL, AC ;
ROGGENDORF, W ;
KUSTERMANNKUHN, B ;
POULOS, A ;
CAREY, WF ;
HARZER, K .
EUROPEAN JOURNAL OF PEDIATRICS, 1989, 148 (06) :558-562
[6]   SPHINGOLIPID ACTIVATOR PROTEIN-DEFICIENCY IN A 16-WEEK-OLD ATYPICAL GAUCHER DISEASE PATIENT AND HIS FETAL SIBLING - BIOCHEMICAL SIGNS OF COMBINED SPHINGOLIPIDOSES [J].
HARZER, K ;
PATON, BC ;
POULOS, A ;
KUSTERMANNKUHN, B ;
ROGGENDORF, W ;
GRISAR, T ;
POPP, M .
EUROPEAN JOURNAL OF PEDIATRICS, 1989, 149 (01) :31-39
[7]   Mutation analysis of the acid ceramidase gene in Japanese patients with Farber disease [J].
Muramatsu, T ;
Sakai, N ;
Yangihara, I ;
Yamada, M ;
Nishigaki, T ;
Kokubu, C ;
Tsukamoto, H ;
Ito, M ;
Inui, K .
JOURNAL OF INHERITED METABOLIC DISEASE, 2002, 25 (07) :585-592
[8]   Acid ceramidase and human disease [J].
Park, Jae-Ho ;
Schuchman, Edward H. .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (12) :2133-2138
[9]   In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease [J].
Ramsubir, Shobha ;
Nonaka, Takahiro ;
Girbes, Carmen Bedia ;
Carpentier, Stephane ;
Levade, Thierry ;
Medin, Jeffrey A. .
MOLECULAR GENETICS AND METABOLISM, 2008, 95 (03) :133-141
[10]  
Thierry Levade KS, 2010, ONLINE METABOLIC MOL